NASDAQ · Financial Statements
IDEX Biometrics ASA (IDBA) Financial Statements
$4.88
NASDAQ: IDBA
Market Cap $90.79M
Overview Financials Dividend
IDEX Biometrics ASA most recently reported annual revenue of $4.0M, a net loss of $27.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023
Revenue $4.0M $1.0M $3.0M $4.0M $4.0M Operating Profit $-281.0M $-26.0M $-31.0M $-31.0M $-27.0M Net Profit $-32.0M $-27.0M $-33.0M $-33.0M $-27.0M EPS $-0.27 $-0.17 $-0.18 $-0.16 $-1.07 Op Margin -7558.3% -2411.1% -1103.9% -766.6% -648.6%
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023
Total Assets $23.0M $17.0M $42.0M $29.0M $25.0M Total Liabilities $6.0M $4.0M $4.0M $6.0M $14.0M Cash $14.0M $7.0M $34.0M $16.0M $11.0M Borrowings $12.0M $1.0M $0 $12.0M $7.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023
Operating Cash Flow $-28.0M $-23.0M $-27.0M $-32.0M $-27.0M Investing Cash Flow $-2.0M $-1.0M $0 $0 $0 Financing Cash Flow $5.0M $0 $0 $0 $-58.0M Net Cash Flow $5.0M $-7.0M $27.0M $-18.0M $-4.0M Free Cash Flow $-28.0M $-24.0M $-28.0M $-32.0M $-27.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.02 EV / EBITDA -0.32 FCF Yield -30.11% Quick Ratio 1.12 Interest Coverage -40.38 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .